Revvity (NYSE:RVTY) Sets New 12-Month High – Time to Buy?

Revvity Inc. (NYSE:RVTY)’s stock price hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $166.25 and last traded at $153.3340, with a volume of 2678173 shares traded. The stock had previously closed at $157.36.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Sanford C. Bernstein assumed coverage on Revvity in a research note on Friday, June 26th. They issued a “market perform” rating and a $115.00 target price for the company. William Blair assumed coverage on Revvity in a report on Monday. They issued an “outperform” rating for the company. TD Cowen reissued a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Barclays boosted their target price on shares of Revvity from $115.00 to $160.00 and gave the company an “equal weight” rating in a report on Wednesday. Finally, Zacks Research upgraded shares of Revvity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 4th. Five equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to MarketBeat.com, Revvity currently has an average rating of “Hold” and an average price target of $120.50.

Revvity Stock Down 0.9%

The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. The stock has a 50 day simple moving average of $131.65 and a 200-day simple moving average of $110.77. The firm has a market cap of $16.99 billion, a PE ratio of 72.52, a PEG ratio of 2.79 and a beta of 1.06.

Revvity (NYSE:RVTY) last released its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. During the same period in the prior year, the firm posted $1.18 earnings per share. The company’s quarterly revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Sell-side analysts predict that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s dividend payout ratio is 13.33%.

Insider Transactions at Revvity

In other Revvity news, insider Tajinder Vohra sold 7,330 shares of Revvity stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total value of $1,032,650.40. Following the completion of the transaction, the insider directly owned 6,635 shares of the company’s stock, valued at approximately $934,738.80. The trade was a 52.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Maxwell Krakowiak sold 1,631 shares of the company’s stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $144.53, for a total transaction of $235,728.43. Following the completion of the transaction, the insider owned 14,781 shares in the company, valued at approximately $2,136,297.93. This represents a 9.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 9,130 shares of company stock valued at $1,290,745. 0.85% of the stock is owned by company insiders.

Hedge Funds Weigh In On Revvity

A number of hedge funds have recently added to or reduced their stakes in the company. Ascentis Independent Advisors purchased a new stake in Revvity during the 1st quarter valued at $29,000. SJS Investment Consulting Inc. raised its stake in shares of Revvity by 5,210.0% in the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after purchasing an additional 521 shares during the last quarter. Global Retirement Partners LLC bought a new position in shares of Revvity during the second quarter valued at $51,000. Summit Securities Group LLC lifted its holdings in shares of Revvity by 294.6% during the first quarter. Summit Securities Group LLC now owns 663 shares of the company’s stock valued at $58,000 after purchasing an additional 495 shares in the last quarter. Finally, Contravisory Investment Management Inc. purchased a new stake in shares of Revvity during the first quarter valued at $66,000. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Revvity Company Profile

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.